BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18506278)

  • 1. [In hospital care for diabetic foot: a comparison between the estimated cost and the SUS reimbursement].
    Rezende KF; Nunes MA; Melo NH; Malerbi D; Chacra AR; Ferraz MB
    Arq Bras Endocrinol Metabol; 2008 Apr; 52(3):523-30. PubMed ID: 18506278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual Direct Medical Costs of Diabetic Foot Disease in Brazil: A Cost of Illness Study.
    Toscano CM; Sugita TH; Rosa MQM; Pedrosa HC; Rosa RDS; Bahia LR
    Int J Environ Res Public Health; 2018 Jan; 15(1):. PubMed ID: 29316689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The costs of diabetic foot: the economic case for the limb salvage team.
    Driver VR; Fabbi M; Lavery LA; Gibbons G
    J Vasc Surg; 2010 Sep; 52(3 Suppl):17S-22S. PubMed ID: 20804928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic foot ulcers in a multidisciplinary setting. An economic analysis of primary healing and healing with amputation.
    Apelqvist J; Ragnarson-Tennvall G; Persson U; Larsson J
    J Intern Med; 1994 May; 235(5):463-71. PubMed ID: 8182403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of diabetic foot disease to the National Health Service in England.
    Kerr M; Rayman G; Jeffcoate WJ
    Diabet Med; 2014 Dec; 31(12):1498-504. PubMed ID: 24984759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of diabetic foot lesions in hospital: costs and benefits.
    Benotmane A; Mohammedi F; Ayad F; Kadi K; Medjbeur S; Azzouz A
    Diabetes Metab; 2001 Dec; 27(6):688-94. PubMed ID: 11852378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends and determinants of costs associated with the inpatient care of diabetic foot ulcers.
    Hicks CW; Selvarajah S; Mathioudakis N; Perler BA; Freischlag JA; Black JH; Abularrage CJ
    J Vasc Surg; 2014 Nov; 60(5):1247-1254.e2. PubMed ID: 24939079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting.
    Apelqvist J; Ragnarson-Tennvall G; Larsson J; Persson U
    Foot Ankle Int; 1995 Jul; 16(7):388-94. PubMed ID: 7550950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidisciplinary clinics reduce treatment costs and improve patient outcomes in diabetic foot disease.
    Joret MO; Osman K; Dean A; Cao C; van der Werf B; Bhamidipaty V
    J Vasc Surg; 2019 Sep; 70(3):806-814. PubMed ID: 30850290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Losing a foot versus losing a dollar; a systematic review of cost studies in diabetic foot complications.
    Petrakis I; Kyriopoulos IJ; Ginis A; Athanasakis K
    Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):165-180. PubMed ID: 28283002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics and medical costs of diabetics with amputation at central urban hospitals in China].
    Wang AH; Xu ZR; Ji LN;
    Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(4):224-7. PubMed ID: 22490790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of medical intervention in patients with early detection of diabetic foot in a tertiary care hospital in Bangladesh.
    Habib SH; Biswas KB; Akter S; Saha S; Ali L
    J Diabetes Complications; 2010; 24(4):259-64. PubMed ID: 19231246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The financial burden of surgical and endovascular treatment of diabetic foot wounds.
    Joret MO; Dean A; Cao C; Stewart J; Bhamidipaty V
    J Vasc Surg; 2016 Sep; 64(3):648-55. PubMed ID: 27565588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of Patients Admitted for Diabetic Foot Problems.
    Tan JH; Hong CC; Shen L; Tay EY; Lee JK; Nather A
    Ann Acad Med Singap; 2015 Dec; 44(12):567-70. PubMed ID: 27090076
    [No Abstract]   [Full Text] [Related]  

  • 15. Hospitalization costs of severe bacterial pneumonia in children: comparative analysis considering different costing methods.
    Nunes SEA; Minamisava R; Vieira MADS; Itria A; Pessoa VP; Andrade ALSS; Toscano CM
    Einstein (Sao Paulo); 2017; 15(2):212-219. PubMed ID: 28767921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technology-enabled remote management of diabetes foot disease and potential for reduction in associated health costs: a pilot study.
    Main F; Zubala A; Gorman J; Jones S; Hall J; Macfarlane D; MacRury S
    J Foot Ankle Res; 2021 Jan; 14(1):7. PubMed ID: 33436028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-economic consequences of diabetic foot lesions.
    Ragnarson Tennvall G; Apelqvist J
    Clin Infect Dis; 2004 Aug; 39 Suppl 2():S132-9. PubMed ID: 15306992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost of diabetic foot ulcers and amputations to the National Health Service in England.
    Kerr M; Barron E; Chadwick P; Evans T; Kong WM; Rayman G; Sutton-Smith M; Todd G; Young B; Jeffcoate WJ
    Diabet Med; 2019 Aug; 36(8):995-1002. PubMed ID: 31004370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographic variation in Medicare spending and mortality for diabetic patients with foot ulcers and amputations.
    Sargen MR; Hoffstad O; Margolis DJ
    J Diabetes Complications; 2013; 27(2):128-33. PubMed ID: 23062327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs of Real-Life Endovascular Treatment of Critical Limb Ischemia: Report from Poland-A European Union Country with a Low-Budget Health Care System.
    Krzanowski M; Drelicharz L; Belowski A; Partyka L; Sumek-Brandys B; Ramakrishnan PK; Nizankowski R
    Ann Vasc Surg; 2016 Feb; 31():111-23. PubMed ID: 26616505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.